This inventor holds 1 USPTO granted patent. Top assignees: St. Jude Children's Research Hospital, University of Massachusetts. Active years: 2000.
Company Filing History:
1 out of 281 
1 out of 1,625 
Years Active: 2000
Title: Shari Meyers: Innovator in Nuclear Matrix Targeting Peptides
Introduction
Shari Meyers is a notable inventor based in Shreveport, Louisiana. She has made significant contributions to the field of biotechnology, particularly in the development of nuclear matrix targeting peptides. Her innovative work has the potential to enhance therapeutic and diagnostic applications in cellular biology.
Latest Patents
Shari Meyers holds a patent for an "Isolated nuclear matrix targeting peptide." This patent describes nuclear matrix targeting peptides (NMTPs) that are capable of delivering a variety of therapeutic and diagnostic agents, such as transcription regulatory factors, directly to the nuclear matrix of a cell. This advancement could lead to improved methods for treating various diseases at the cellular level.
Career Highlights
Throughout her career, Shari has worked with prestigious institutions, including St. Jude Children's Research Hospital and the University of Massachusetts. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Shari has collaborated with notable colleagues such as Gary S. Stein and Andre J. Van Wijnen. These partnerships have further enriched her research and expanded the impact of her innovations.
Conclusion
Shari Meyers is a pioneering inventor whose work in nuclear matrix targeting peptides holds promise for advancing therapeutic and diagnostic techniques. Her contributions to biotechnology continue to inspire future innovations in the field.